← All companies
Oscar Health, Inc.
OSCR - CIK 0001568651
Market cap$6.76 B
Rank#1176
SEC filings526
Oscar Health, Inc. trades as OSCR and has a market capitalization of $6.76 B, making it the #1176 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $28.59M, up 39.0% from the prior year and net income of -$443.15M. This page tracks Oscar Health, Inc. through 526 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$28.59MFY 2025
Net income (latest FY)-$443.15MFY 2025
Operating cash flow (latest FY)$1.09BFY 2025
Total assets (latest FY)$6.33BFY 2025
Net margin-1549.9%latest FY
Financial performance
Over the last 6 fiscal years Oscar Health, Inc.'s revenue declined from $488.19M to $28.59M, a compound annual decline rate of 37.7%. Net profit margin compressed from -53.5% to -1549.9% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $6.76 B
- EPS (diluted)FY 2025
- $-1.69
- Total equityas of 2026-03-31
- $1.66B
- Return on equity
- -26.6%
- Long-term debtas of 2026-03-31
- $430.88M
- Cash & equivalentsas of 2026-03-31
- $4.81B
- Stock buybacksFY 2021
- $0.00
- Current ratioas of 2026-03-31
- 1.09
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-06 |
| Annual report to shareholders | ARS | 2026-04-22 |
| Proxy materials | DEFA14A | 2026-04-22 |
Recent press releases
- Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance2026-05-06
“Oscar Health drove solid first-quarter performance with significant year-over-year improvements across our core metrics,” said Mark Bertolini, CEO of Oscar Health. “We are reaffirming our guidance and remain on track to significantly expand margins and achieve meaningful profitability in 2026. Consumers expect to shop for healthcare like everyday products – on choice, price, and value. Oscar’s exceptional technology, lifestyle products, and member experience deliver exactly that. The workforce is shifting, the individual market is resilient, and Oscar is leading the transition to a consumer-driven health economy.”
- Oscar Health, Inc. Appoints Director Siddhartha Sankaran as Independent Chair of the Board2026-04-21
Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced the appointment of independent director Siddhartha Sankaran as Chair of the Board, effective June 4, 2026. Sankaran will succeed Jeffery Boyd, who has served as Chair since February 2021 and is not standing for reelection at Oscar Health’s Annual Meeting.
- Meet Lucie. A New Way to Shop for Healthcare.2026-04-20
Oscar Health, Inc. (NYSE: OSCR) today launched Lucie Health Marketplace, a new all-in-one storefront that begins to change how America shops for healthcare. Lucie connects consumers and brokers to every major individual market plan and a curated menu of ancillary and supplemental products.
- Oscar Health, Inc. 2026 First Quarter Earnings Conference Call
Similar companies
The largest companies sharing Oscar Health, Inc.'s SEC industry classification (hospital & medical service plans).
Frequently asked questions
What is Oscar Health, Inc.'s market cap?
Oscar Health, Inc. (OSCR) has a market capitalization of $6.76 B as of 2026-05-29, ranking #1176 among US-listed companies.
How much revenue does Oscar Health, Inc. make?
Oscar Health, Inc. reported revenue of $28.59M for fiscal year 2025, an increase of 39.0% year over year.
Is Oscar Health, Inc. profitable?
In its latest fiscal year Oscar Health, Inc. reported a net loss of $443.15M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.